Ranitidina20 solution for injection

Ranitidina20 solution for injection

ANTIACIDS

Presentation:

Vial containing 50 mL

Species:

Composition

Ranitidine hydrochloride 20 mg.
Excipients q.s. 1 mL

Therapeutic Action

Antacid, H2-receptor antagonist. 

Indications for Use

Indicated for the treatment of gastritis and gastric or duodenal ulcers. Since it inhibits stomach acid secretion, it is indicated for all cases in which heartburn needs to be reduced.

Route of Administration

Intramuscular (IM), subcutaneous (SC) or slow intravenous (IV), previously diluted.

Dosage and Instructions for Use

It can be administered by the following routes: Intramuscular (IM), subcutaneous (SC) or slow intravenous (IV), previously diluted.
Dogs: Administer 2 mg/ kg body weight, equivalent to 1mL every 10 kg body weight. Repeat every 12 hours.
Cats: Administer 2.5 mg/ kg body weight, equivalent to 1mL every 8 kg body weight. Repeat every 12 hours.
Duration of treatment will depend on the severity of the symptoms. Treatment can begin with parenteral administration of the product followed by oral administration. Dose and treatment shall be determined by the prescribing Veterinary Surgeon.

Contraindications / Warnings / Precautions

Even though several side effects have been reported in human beings, such effects have not been verified in animals. Rebound hypersecretion of gastric acid may be observed in some animals after withdrawal of the drug, especially in cases of ulcer. Gastric acid suppression caused by H2-receptors antagonists results in an increase in the plasma concentration of gastrin, 3 hours after administering a dose. The subsequent stimulation of gastric mucosal G cells produces hypersecretion of gastric acid, which becomes evident when the drug is withdrawn.
The probability of hypersecretion is conditioned to an increase in the sensibility of parietal cell receptors that, apparently, characterizes patients suffering from ulcers.

Available

- Argentina
- Perú
- Hong Kong